Page 120 - 南京医科大学自然版
P. 120

第44卷第4期
               ·558 ·                            南 京    医 科 大 学 学         报                        2024年4月


                                      表1 利用单细胞测序获得的与妇科恶性肿瘤相关的关键发现
                        Table 1 Key findings relating to gynecological malignancies obtained using single⁃cell sequencing

                 Tumor         Technology                                Key findings
                  CC     scRNA⁃seq,ST⁃seq       Produced a spatial map illustrating the four developmental stages of HPV⁃related
                                                                                               [20]
                                                CC and identified three distinct‘HPV⁃related epithelial clusters’
                         scRNA⁃seq              Revealed dynamic changes in the TME during the progression of CC,the primary
                                                tumor exhibited an immune ⁃ suppressive state,whereas an immune response in
                                                metastatic lymph nodes was activated [34]
                         scRNA⁃seq              Revealed that squamous and columnar epithelia originate from distinct lineage ⁃
                                                specific populations of ectocervical resident stem cells;These stem cell populations
                                                were regulated by opposing Wnt signals from the stroma,and disruption of Wnt sig⁃
                                                                    [21]
                                                naling led to carcinogenesis
                  OC     scRNA⁃seq,bulk⁃seq     Identified seven subtypes within the primary tumor,and among them,the CYR61 +
                                                                                                       +
                                                subtype was determined to be associated with recurrence,while the RGS5 CAF
                                                subtype promoted tumor metastasis;CYR61 and RGS5 could serve as predictive
                                                factors for recurrent EOC [23]
                         scCOOL⁃seq             Revealed mechanisms associated with the upregulation of genes involved in IFN
                                                signaling transduction,metallothioneins,and metabolism in OC;established new
                                                                                    [25]
                                                potential therapeutic targets for the treatment of OC
                         scRNA⁃seq              Revealed the cellular landscape of HGSOC and elucidated the mechanisms by
                                                which mCAFs enhance the invasive capabilities of ovarian tumor cells;detected
                                                TIGIT as a potential immunotherapeutic molecular target for HGSOC [35]
                         scRNA⁃seq              Elucidated the distinct functions exercised by different cell types within the HG⁃
                                                SOC ascites ecosystem. The communication and interaction among these different
                                                cells may play a balancing role in disease progression and response to treatment.
                                                Consequently,altering this balance therapeutically could be a therapeutic pathway
                                                to reshaping the drug⁃resistant environment [38]
                         scRNA⁃seq,TCR⁃seq      Depicted the single ⁃ cell landscape of five sites associated with OC,including
                                                omentum metastasis and malignant ascites;revealed the interconnections between
                                                                                  [39]
                                                the malignant ascites ecosystem and tumor sites
                  EC     scRNA⁃seq              Identified a characteristic subpopulation associated with the development of EEC,
                                                which is rarely expressed in normal endometrial tissue,but shows an increasing ex⁃
                                                pression pattern in AEH and EEC [31]
                         scRNA⁃seq              Revealed ciliated cell markers DYDC2,CTH,FOXJ1,and p73 as well as the se⁃
                                                cretory cell marker MPST,which can be utilized to improve clinical risk stratifica⁃
                                                              [32]
                                                tion for EC patients
                         scRNA⁃seq              Detected the presence of the mature tertiary lymphoid structure marker L1CAM,
                                                which serves as a TLS immunohistochemical marker,improving the accuracy of
                                                predicting recurrence and prognosis in EC patients [36]
                         scDNA⁃seq,scRNA⁃seq,   Identified molecular biomarkers such as PIK3R1 and CTNNB1 which contribute
                         single⁃cell proteomics  to the investigation of drug resistance mechanisms in EC and guide stratified man⁃
                                                                                        [40]
                                                agement and precision treatment research for EC patients



             [参考文献]                                                  CA Cancer J Clin,2021,71(3):209-249
                                                                [2] ZHENG R,ZHANG S,ZENG H,et al. Cancer incidence
             [1] SUNG H,FERLAY J,SIEGEL R L,et al. Global cancer
                                                                     and mortality in China,2016[J]. J Natl Cancer Cent,
                   statistics 2020:GLOBOCAN estimates of incidence and
                                                                     2022,2(1):1-9
                   mortality worldwide for 36 cancers in 185 countries[J].  [3] ALFANO C M,LEACH C R,SMITH T G,et al. Equitably
   115   116   117   118   119   120   121   122   123   124   125